EXPERIENCE WITH TWO PATIENTS WITH ACTIVATED PI3K DELTA SYNDROME: CASE REPORTS

被引：0
|
作者：
Stoner, A.
Kennedy, J.
Berlinski, A.
Jones, S.
Scurlock, A.
机构：
来源：
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY | 2017年 / 119卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
P271
引用
收藏
页码：S69 / S69
页数：1
相关论文
共 50 条
  • [31] Annual rates of activated PI3K delta syndrome manifestations using physician-derived survey data
    Harrington, A.
    Wu, E. Y.
    Hartog, N. L.
    Rider, N. L.
    Chandrakasan, S.
    Lopes, J. P.
    Aggarwal, S.
    ALLERGY, 2023, 78
  • [32] Annual rates of treatment for activated PI3K delta syndrome using physician-derived survey data
    Harrington, A.
    Hartog, N. L.
    Wu, E. Y.
    Rider, N. L.
    Chandrakasan, S.
    Lopes, J. P.
    Aggarwal, S.
    ALLERGY, 2023, 78
  • [33] CHILD WITH ACTIVATED PI3K DELTA SYNDROME WHO DEVELOPED STEVENS-JOHNSON SYNDROME SECONDARY TO AMOXICILLIN CLAVULANIC ACID
    Kuhn, J.
    Gans, M.
    Pundit, V.
    Rao, K.
    Kleiner, G.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2023, 131 (05) : S104 - S104
  • [34] Dissecting the cellular defects that lead to activated PI3K δ Syndrome (APDS)
    Lau, Anthony
    Bier, Julia
    Brink, Robert
    Tangye, Stuart
    Deenick, Elissa
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2021, 51 : 110 - 110
  • [35] Clinical, Immunological, and Genetic Features in Patients with Activated PI3Kδ Syndrome (APDS): a Systematic Review
    Mahnaz Jamee
    Shakiba Moniri
    Majid Zaki-Dizaji
    Peter Olbrich
    Reza Yazdani
    Farhad Jadidi-Niaragh
    Fatemeh Aghamahdi
    Hassan Abolhassani
    Alison M. Condliffe
    Asghar Aghamohammadi
    Gholamreza Azizi
    Clinical Reviews in Allergy & Immunology, 2020, 59 : 323 - 333
  • [36] Clinical, Immunological, and Genetic Features in Patients with Activated PI3Kδ Syndrome (APDS): a Systematic Review
    Jamee, Mahnaz
    Moniri, Shakiba
    Zaki-Dizaji, Majid
    Olbrich, Peter
    Yazdani, Reza
    Jadidi-Niaragh, Farhad
    Aghamahdi, Fatemeh
    Abolhassani, Hassan
    Condliffe, Alison M.
    Aghamohammadi, Asghar
    Azizi, Gholamreza
    CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY, 2020, 59 (03) : 323 - 333
  • [37] Safety and Efficacy of Long Term Suppression of PI3Kinase Pathway By Small Molecule PI3K-Delta Inhibitor, Leniolisib in Apds (Activated PI3Kδ Syndrome)
    Rao, V. Koneti
    Webster, Sharon
    Dalm, Virgil A. S. H.
    Sediva, Anna
    van Hagen, P. Martin
    Do, H. Michael
    Folio, Les
    Cabanski, Maciej
    Valentin, Marie-Anne
    de Buck, Stefan
    Kalis, Christoph
    Hasselberg, Anke
    Burkhart, Christoph
    Kucher, Klaus
    Sloth, Birgitte
    Uzel, Gulbu
    BLOOD, 2018, 132
  • [38] Effective "activated PI3Kδ syndrome"-targeted therapy with the PI3Kd inhibitor leniolisib
    Rao, V. Koneti
    Webster, Sharon
    Dalm, Virgil A. S. H.
    Sediva, Anna
    van Hagen, P. Martin
    Holland, Steven
    Rosenzweig, Sergio D.
    Christ, Andreas D.
    Sloth, Birgitte
    Cabanski, Maciej
    Joshi, Aniket D.
    de Buck, Stefan
    Doucet, Julie
    Guerini, Danilo
    Kalis, Christoph
    Pylvaenaeinen, Ilona
    Soldermann, Nicolas
    Kashyap, Anuj
    Uzel, Gulbu
    Lenardo, Michael J.
    Patel, Dhavalkumar D.
    Lucas, Carrie L.
    Burkhart, Christoph
    BLOOD, 2017, 130 (21) : 2307 - 2316
  • [39] Clinical features and treatment of activated PI3K-delta syndrome in Peruvian children: A case series
    Toribio-Dionicio, Crhistian
    Eliana Veramendi-Espinoza, Liz
    Luna-Peralta, Gerardo
    Gavino-Alarcon, Franz
    Jara-Rodas, Catherine
    Cordova-Calderon, Wilmer
    Carlos Aldave, Juan
    CLINICAL IMMUNOLOGY, 2023, 250 : 8 - 8
  • [40] Expert insights on Hodgkin's lymphoma development in an activated PI3K delta syndrome patient undergoing leniolisib treatment
    Conti, Francesca
    Moratti, Mattia
    Sabattini, Elena
    Zinzani, Pier Luigi
    FRONTIERS IN IMMUNOLOGY, 2025, 15
12345